日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RuBi-Ruxolitinib: A Photoreleasable Antitumor JAK Inhibitor

RuBi-Ruxolitinib:一种光释放型抗肿瘤JAK抑制剂

Rafic, Estefania; Ma, Cindy; Shih, Bobby B; Miller, Hannah; Yuste, Rafael; Palomero, Teresa; Etchenique, Roberto

Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma.

罗米地辛和阿法替尼可消除 Jak 信号转导和转录激活因子信号传导,并在皮肤 T 细胞淋巴瘤中产生协同抗肿瘤作用

Shih Bobby B, Ma Cindy, Cortes Jose R, Reglero Clara, Miller Hannah, Quinn S Aidan, Albero Robert, Laurent Anouchka P, Mackey Adam, Ferrando Adolfo A, Geskin Larisa, Palomero Teresa